Effects of NF-κB Inhibitor,Caffeic Acid Phenethyl Ester, on Early Airway Remodeling of Mice Induced with Acrolein

李艳萍,刘代顺,文富强,冯玉麟,李万成,刘维佳
DOI: https://doi.org/10.3969/j.issn.1002-0179.2007.02.055
2007-01-01
Abstract:Objective:To investigate the effect of caffeic acid phenethyl ester(CAPE),an inhibitor of NF-κB on early airway remodeling of mice inhaled with acrolein fog for two weeks.Methods:Early airway remodeling model of mice was established with acrolein inhalation 6 h per day for two weeks.Twenty-four C57BL/6 mice were randomly divided into four groups(n=6 in each group).Mice with or without acrolein inlation were intraperitonealy injected with CAPE 30 mg/kg qod,and saline was administered in control mice.Lung tissue sections were stained with HE,Masson and evaluated with Ashcroft scores.Hydroxyproline concentration of lung tissues was detected.Total and differential cell count and TGF-β1 concentration in BALF were carried out by microscopy and ELISA,respectively.Results:Comparing with control,increased airway inflammation,smooth muscle cells proliferation and sub-epithelial collagen deposition were observed in mice inhaled with acrolein fog(P0.05),which was significantly reduced after the treatment with CAPE(P0.05).Accordingly,the increased release of TGF-β1 in BALF from mice inhaled with acrolein was attenuated with CAPE.Conclusion:Through decreased release of TGF-β1,NF-κB inhibitor CAPE inhibits acrolein-induced inflammation and development in early airway remodeling.
What problem does this paper attempt to address?